Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

Share Price is delayed by 15 minutes
Get Live Data
2.65    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.30 (12.00%)
Market Cap: £1.39m
CHLL Live PriceLast checked at - London Stock Exchange

Intraday Chill Brands Share Chart

Strategic partnership with SYP Global

8 Sep 2025 07:00

RNS Number : 2939Y
Chill Brands Group PLC
08 September 2025
 

 

 

8 September 2025

Chill Brands Group plc

("Chill Brands" or the "Company")

 

Strategic partnership with SYP Global

 

Chill Brands Group Plc (LSE: CHLL), the consumer packaged-goods distribution company, is pleased to announce that it has entered into a strategic partnership with SYP Global Limited ("SYP"), a company developing a pioneering new nicotine delivery system.

 

SYP is developing a new nicotine delivery technology that fundamentally differs from conventional electronic nicotine systems. The platform avoids heating elements and using the solvents typically found in conventional vape liquid, thereby preventing the formation of harmful thermal by-products such as carbonyl compounds and metallic particles. This reduction in potential toxicant exposure is expected to deliver a cleaner aerosol profile and a smoother user experience compared with existing nicotine delivery devices. Chill Brands' Directors believe that SYP's product could represent a first-to-market innovation in the nicotine alternatives category.

Chill Brands has been appointed as SYP's brand expansion partner, responsible for supporting the development of the brand and facilitating its route to market through Chill Connect's established distribution network. As part of the partnership, Chill Brands' Chief Executive Officer, Callum Sommerton, will join the Board of Directors of SYP Global Limited. In this capacity, he will support the development, commercialisation and intellectual property protection of SYP's technology while facilitating cooperation with Chill Connect, which will be used to run in-market trials with the intention of progressing to distribute future SYP products at scale.

 

The technology is under development and is expected to be in a form ready for commercial sale within 12 months. It is therefore not expected to generate revenue for the Company in the immediate term. While no guarantees can be made as to its ultimate success or regulatory acceptance, the Company's Directors believe that alignment with SYP at this early stage represents a high-potential opportunity for Chill Brands. For the avoidance of doubt, Chill Brands has not made an equity investment in SYP as part of this strategic partnership and is not funding the development of the product. Both SYP and Chill Brands will provide further updates on progress as and when it is appropriate to do so.

 

Callum Sommerton, Chief Executive Officer of Chill Brands, commented:

 

"We are delighted to have partnered with SYP and look forward to being a part of the journey as they develop this groundbreaking technology.

 

This is a phenomenal opportunity for the Company to align itself with a truly novel nicotine delivery platform from the very beginning. It is rare to encounter a technology that has the potential to reshape an industry, and I believe that SYP has the chance to do just that - offering consumers a clean alternative that works without heating and supports both oral and inhaled intake of active ingredients.

 

This step reflects Chill Brands' model as a route-to-market partner for high-quality, novel products, and underlines our commitment to bringing the most innovative technologies to market while working closely to shape their development and guide them towards commercial success.

 

We look forward to seeing SYP's technology progress from prototype to pre-market trials, and to leverage our Chill Connect network to deliver this innovation to retailers throughout the UK."

 

Christof Niederberger, Founder of SYP, commented:

"After years of dedicated development, we are proud to have reached the first working prototypes of what we believe will be a category-defining innovation in nicotine delivery.

SYP may be a young company, but this technology has been years in the making, and we have every confidence it will reach the market and reshape the smoking and vaping landscape.

The strategic partnership with Chill Brands gives us an invaluable ally with the experience, distribution strength, and brand-building credentials to help shape our journey. We are genuinely excited to be working so closely with Callum and his team as we bring this pioneering product closer to launch."

 

-ENDS-

 

Media enquiries:

Chill Brands Group plc

Harry Chathli, Chairman

Callum Sommerton, CEO

contact@chillbrandsgroup.com+44 (0)20 4582 3500

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor/Lauren Wright (Corporate Finance)Kelly Gardiner (Equity Sales)

 

 

About Chill Brands Group

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is a distribution-led consumer packaged goods company focused on bringing novel fast-moving consumer products (FMCG) to market. The Company specialises in the sale and distribution of tobacco alternatives, functional beverages, and other innovative consumer goods, with a particular emphasis on the convenience store channel. Chill Brands partners with a mix of established FMCG businesses and emerging high-potential brands to provide comprehensive route-to-market solutions. Chill Brands also operates the chill.com e-commerce website, on which it is building a marketplace of products from third-party brands.

 

Publication on website

A copy of this announcement is also available on the Group's website at http://www.chillbrandsgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRQELFBEKLEBBZ
Date   Source Headline
29th May 20264:41 pmRNSShare Capital Reorganisation, PDMR & TVR
19th May 20267:00 amRNSUpdated Timetable for Share Capital Reorganisation
13th May 20263:27 pmRNSResult of AGM
13th May 20267:00 amRNSCommercial Update Ahead of AGM
23rd Apr 20267:00 amRNSCommercial Update
20th Apr 20262:00 pmRNSNotice of AGMs & Share Capital Reorganisation
31st Mar 20267:00 amRNSDirectorate change
9th Feb 20267:00 amRNSTrading Update
25th Nov 20257:00 amRNSChange of Auditor
31st Oct 20255:00 pmRNSTotal Voting Rights
23rd Oct 20257:00 amRNSChill Agrees Settlement with Former Advisers
20th Oct 20257:00 amRNSBusiness and strategy update
1st Oct 20255:21 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSIssue of Equity
19th Sep 20251:30 pmRNSREPLACEMENT-Chill Brands appointed UK Distributor
10th Sep 20257:00 amRNSChill appointed Distributor - ELF Nicotine Pouches
8th Sep 20257:00 amRNSStrategic partnership with SYP Global
5th Sep 202511:00 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSChill Appointed UK Distribution Partner by RELX
22nd Aug 202512:30 pmRNSHolding(s) in Company
11th Aug 20257:45 amRNSCompany Update and Lifting of Suspension
11th Aug 20257:30 amRNSRestoration - Chill Brands Group plc
31st Jul 202512:30 pmRNSInterim Results for the 12 months to 31 March 2025
28th Jul 20257:00 amRNSChange of Accounting Reference Date
11th Jul 20251:00 pmRNSHalf-year Report for the 6 months to 30 Sep 2024
23rd Jun 20257:00 amRNSAnnual Financial Report to 31 March 2024
30th May 20257:00 amRNSUpdate on the publication of financial results
23rd May 20257:00 amRNS£1m raised from issuance of convertible loan notes
24th Apr 20257:00 amRNSFundraising to raise £1m & Update on results
26th Mar 202512:00 pmRNSStatus of audit and publication of accounts
11th Mar 20257:00 amRNSUpdate on Current Business & Proposed Fundraising
19th Dec 20247:00 amRNSCorporate update
9th Dec 20247:00 amRNSCompany Update
30th Sep 20244:30 pmRNSResult of AGM
30th Sep 20247:00 amRNSAGM Statement & Trading Update
5th Sep 20247:00 amRNSDirectorate Change & Notice of AGM
25th Jul 20244:20 pmRNSCommencement of Legal Action
17th Jul 20247:00 amRNSCompany Update & Directorate Changes
10th Jun 20247:00 amRNSDirectorate Change & Company Update
4th Jun 20241:10 pmRNSResult of GM and Board Changes
3rd Jun 20247:53 amRNSSuspension of Trading in Shares
7th May 20245:31 pmRNSPosting of General Meeting Documents
7th May 20242:04 pmRNSNotice of GM
22nd Apr 20247:00 amRNSSuspension of CEO
17th Apr 20243:18 pmRNSReceipt of Requisition Letter
16th Apr 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSInvestor Presentation via Investor Meet Company
31st Jan 20245:00 pmRNSTotal Voting Rights
29th Jan 20247:00 amRNSResponse to Government Proposals
26th Jan 20247:00 amRNSEquity Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.